补肾疏肝调周法治疗多囊卵巢综合征高雄激素血症的临床观察

被引:0
作者
刘玲玲
机构
[1] 黑龙江中医药大学
关键词
多囊卵巢综合征; 高雄激素血症; 中药调周法;
D O I
暂无
年度学位
2015
学位类型
硕士
导师
摘要
目的:通过补肾疏肝调周法治疗多囊卵巢综合征高雄激素血症的临床观察,评价补肾疏肝调周中药的临床疗效,并探讨可能作用机制,为临床诊疗PCOS提供依据。方法:收集2014年02月-12月就诊于黑龙江中医药大学附属第一医院妇科门诊PCOS高雄激素血症患者33例,给予补肾疏肝调周中药治疗3个月经周期,分别于治疗前后进行相关的实验室检查及临床体征评分。结果:1.治疗前后性激素水平变化,治疗后T、DHEAS、FAI、AND、LH、LH/FSH显著降低;治疗后SHBG、FSH、E2、PRL无明显改变。2.治疗前后临床体征比较,多毛、痤疮、黑棘皮、溢脂、腰臀比、BMI,均无明显改变。3,治疗后FINS、HOMA-IR显著降低;治疗后FPG无明显改变。4.随着服药周期的增加,排卵率越来越高。结论:补肾疏肝调周法可以降低雄激素,改善胰岛素抵抗,调节下丘脑-垂体-卵巢性腺轴功能,提高排卵率,从而达到治疗多囊卵巢综合征的目的。
引用
收藏
页数:41
共 37 条
[1]
Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome [J].
Livadas, Sarantis ;
Pappas, Christos ;
Karachalios, Athanasios ;
Marinakis, Evangelos ;
Tolia, Nikoleta ;
Drakou, Maria ;
Kaldrymides, Philippos ;
Panidis, Dimitrios ;
Diamanti-Kandarakis, Evanthia .
ENDOCRINE, 2014, 47 (02) :631-638
[2]
Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome [J].
Sung, Yeon-Ah ;
Oh, Jee-Young ;
Chung, Hyewon ;
Lee, Hyejin .
FERTILITY AND STERILITY, 2014, 101 (03) :840-845
[3]
Neuroendocrine dysfunction in polycystic ovary syndrome.[J].Christine M. Burt Solorzano;Jennifer P. Beller;Michelle Y. Abshire;Jessicah S. Collins;Christopher R. McCartney;John C. Marshall.Steroids.2011, 4
[4]
Metabolic and Reproductive Features before and during Puberty in Daughters of Women with Polycystic Ovary Syndrome [J].
Sir-Petermann, Teresa ;
Codner, Ethel ;
Perez, Virginia ;
Echiburu, Barbara ;
Maliqueo, Manuel ;
Ladron de Guevara, Amanda ;
Preisler, Jessica ;
Crisosto, Nicolas ;
Sanchez, Fernando ;
Cassorla, Fernando ;
Bhasin, Shalender .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (06) :1923-1930
[5]
Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome [J].
Christakou, Charikleia D. ;
Diamanti-Kandarakis, Evanthia .
WOMENS HEALTH, 2008, 4 (06) :583-594
[6]
The metabolic syndrome in young Korean women with polycystic ovary syndrome.[J].Hwi Ra Park;Youngju Choi;Hye-Jin Lee;Jee-Young Oh;Young Sun Hong;Yeon-Ah Sung.Diabetes Research and Clinical Practice.2007, 3
[7]
Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: Using the International Diabetes Federation criteria [J].
Weerakiet, Sawaek ;
Bunnag, Pongamon ;
Phakdeekitcharoen, Bunyong ;
Wansumrith, Surapee ;
Chanprasertyothin, Suwannee ;
Jultanmas, Rattiya ;
Thakinstian, Ammarin .
GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (03) :153-160
[8]
The metabolic syndrome in polycystic ovary syndrome [J].
Essah, PA ;
Nestler, JE .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2006, 29 (03) :270-280
[9]
Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
[10]
Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome [J].
Glueck, CJ ;
Papanna, R ;
Wang, P ;
Goldenberg, N ;
Sieve-Smith, L .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (07) :908-915